Expiratory Muscle Strength Training for Hypernasal Speech in Children
Expiratory Muscle Strength Training as a Non-surgical Option for Velopharyngeal Dysfunction: A Randomized-controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Amber D Shaffer, PhD
- Phone Number: 412-692-6874
- Email: shafferad@upmc.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15224
- Recruiting
- UPMC Children's Hospital of Pittsburgh
-
Sub-Investigator:
- Cuneyt Alper, MD
-
Sub-Investigator:
- Matthew Ford, MS
-
Sub-Investigator:
- Jesse Goldstein, MD
-
Contact:
- Amber D Shaffer, PhD
- Phone Number: 412-692-6874
- Email: shafferad@upmc.edu
-
Contact:
- Marina V Rushchak, BA
- Phone Number: 412-692-9879
- Email: rushchakmv4@upmc.edu
-
Sub-Investigator:
- Fendi Obuekwe
-
Sub-Investigator:
- Nancy Gauvin, PhD
-
Principal Investigator:
- Noel Jabbour, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Score of 2 or greater on the nasality/resonance domain of the Pittsburgh Weighted Speech Scale
- Ages 5-17 years
Exclusion Criteria:
- CAPS-A-AM hypernasality score <2
- Previous speech surgery (e.g. palatoplasty or pharyngeal flap for speech)
- Speech surgery scheduled within the next 56 days
- Unable or unwilling to perform the tests and exercises outlined in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Expiratory Muscle Strength Training + No Maintenance Training
These participants completed 6-8 weeks of exercises with EMST-150.
They had improvement in their CAPS-A hypernasality rating of 1 point or more and were randomized to complete 6 months of no maintenance training.
|
At visit 1, participants will be block randomized based on PWSS score (5-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises.
Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.
Other Names:
|
|
Experimental: Expiratory Muscle Strength Training + Maintenance Training
These participants completed 6-8 weeks of exercises with EMST-150.
They had improvement in their CAPS-A hypernasality rating of 1 point or more and were randomized to complete 6 months of maintenance training.
|
At visit 1, participants will be block randomized based on PWSS score (5-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises.
Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.
Other Names:
At visit 2, participants with improved (decreased) CAPS-A hypernasality rating of 1 or more points, for whom the family and/or surgeon is not currently considering surgical intervention for VPI, will be further randomized to continue "maintenance" EMST exercises or no exercises for 6 months.
Participants in the "maintenance" group will complete 3-5 sessions exercise sessions each week (rather than daily training), with 2 sets of 5 resistive expirations (rather than 5 sets)
|
|
Experimental: Expiratory Muscle Strength Training
These participants completed 6-8 weeks of exercises with EMST-150.
They did not have improvement in their CAPS-A hypernasality rating of 1 point or more and ended active study participation after the initial 6-8 weeks of exercises.
|
At visit 1, participants will be block randomized based on PWSS score (5-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises.
Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nasalance scores after 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Percent change in nasalance measured during nasometry
|
Baseline and 6-8 weeks
|
|
Change in oral pressure following 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Percent change in oral pressure achieved when blowing through the EMST-150
|
Baseline and 6-8 weeks
|
|
Change in velopharyngeal flutter following 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150
|
Baseline and 6-8 weeks
|
|
Change in oral pressure decay following 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Ratio of the magnitude of oral pressure decay when blowing through the EMST-150
|
Baseline and 6-8 weeks
|
|
Change in perceptual speech symptoms of velopharyngeal dysfunction following 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4.
0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.
|
Baseline and 6-8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in VELO questionnaire scores following 6-8 weeks of exercises compared with baseline
Time Frame: Baseline and 6-8 weeks
|
Percent change in Velopharyngeal Insufficiency (VPI) Effects on Life Outcomes (VELO) scores.
Scores range from 0 - 100, with 100 representing the highest QOL
|
Baseline and 6-8 weeks
|
|
Resolution of type B tympanogram following 6-8 weeks of exercises compared with baseline.
Time Frame: Baseline and 6-8 weeks
|
Percentage of participants with a change in tympanogram type from type B (flat) to type A (normal middle ear function).
|
Baseline and 6-8 weeks
|
|
Resolution of type C tympanogram following 6-8 weeks of exercises compared with baseline.
Time Frame: Baseline and 6-8 weeks
|
Percentage of participants with a change in tympanogram type from type C (negative pressure) to type A (normal middle ear function).
|
Baseline and 6-8 weeks
|
|
Resolution of effusion following 6-8 weeks of exercises compared with baseline.
Time Frame: Baseline and 6-8 weeks
|
Percentage of participants with resolution of middle ear effusion based on otoscopy.
|
Baseline and 6-8 weeks
|
|
Resolution of retraction following 6-8 weeks of exercises compared with baseline.
Time Frame: Baseline and 6-8 weeks
|
Percentage of participants with resolution of tympanic membrane retraction based on otoscopy
|
Baseline and 6-8 weeks
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nasalance scores after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Time Frame: 6-8 weeks and 8 months
|
Percent change in nasalance measured during nasometry
|
6-8 weeks and 8 months
|
|
Change in oral pressure after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Time Frame: 6-8 weeks and 8 months
|
Percent change in pressure achieved when blowing through the EMST-150
|
6-8 weeks and 8 months
|
|
Change in velopharyngeal flutter after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Time Frame: 6-8 weeks and 8 months
|
Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150
|
6-8 weeks and 8 months
|
|
Change in oral pressure decay after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Time Frame: 6-8 weeks and 8 months
|
Ratio of the magnitude of oral pressure decay when blowing through the EMST-150
|
6-8 weeks and 8 months
|
|
Prevalence of surgical intervention
Time Frame: 1 year
|
Percentage of patients undergoing surgical intervention for speech symptoms within the 1 year following enrollment
|
1 year
|
|
Change in perceptual speech symptoms of velopharyngeal dysfunction after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Time Frame: 6-8 weeks and 8 months
|
Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4.
0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.
|
6-8 weeks and 8 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Noel Jabbour, MD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Musculoskeletal Diseases
- Mouth Diseases
- Stomatognathic Diseases
- Jaw Diseases
- Jaw Abnormalities
- Maxillofacial Abnormalities
- Craniofacial Abnormalities
- Musculoskeletal Abnormalities
- Stomatognathic System Abnormalities
- Congenital Abnormalities
- Otorhinolaryngologic Diseases
- Pharyngeal Diseases
- Mouth Abnormalities
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Behavior
- Communication
- Verbal Behavior
- Speech
- Cleft Palate
- Velopharyngeal Insufficiency
- Speech Intelligibility
Other Study ID Numbers
Other Study ID Numbers
- STUDY21120032
- 5R21DC017553-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.